We’re into the flu season again. The U.S. Centers for

Disease Control and Prevention says “36,000 Americans

die of flu-related illness every year” and 90 percent

of flu-related deaths occur among people 65 years and

older. This means one in 1,000 people in that age

bracket is likely to die a flu-related death. The Oct.

25 washingtonpost.com put in context: “The chance of a

flu-related death is slightly lower than the chance of

dying from a fall or other accident.”

 

On Nov. 1, President George W. Bush asked Congress for

$7.1 billion to deal with a future flu epidemic that

may infect 200 million Americans and kill 200,000.

 

In the Oct. 31 Newsweek, in “The Fight Against the

Flu,” it was reported, “There is no question that the

administration is taking the threat of avian flu

seriously” and “epidemiologists agree that a flu

pandemic is inevitable sooner or later.”

 

The head of pandemic-flu preparedness for the World

Health Organization, Dr. Margaret Chan, warned that

historically, “no human intervention” has been able to

stop a pandemic once it starts, but today we can see a

“pandemic unfold before our eyes,” which gives us a

minimal window of “20 to 21 days” to control a local

breakout before it expands exponentially.

 

Newsweek’s Fareed Zakaria wrote in “A Threat Worse

Than Terror” that a crude nuclear device would kill

hundreds of thousands, but a flu pandemic “could

easily kill millions.” Senior fellow for global health

at the Council on Foreign Relations Laurie Garrett,

“The Next Epidemic?” author, told ABC News, “Short of

thermonuclear war, I have a hard time imagining

anything in my lifetime that would be as horrible.”

 

Worth reading are questions and answers on the bird

flu in the Oct. 14 CNN.com’s “Bird flu: What you need

to know.” Avian flu, an infectious disease of birds

caused by type A strains of the flu virus, was

identified in Italy more than 100 years ago. It

normally infects no other species than birds and pigs.

Genetic studies reveal that the virus has very rarely

jumped from birds to humans, but in 1997 in Hong Kong,

18 people were infected with the H5N1 strain, one of

15 avian flu virus subtypes. Six died. Symptoms

included fever, sore throat, cough and, in fatal

cases, severe respiratory distress secondary to viral

pneumonia.

 

In the last few years, the H5N1 strain of avian flu

has pillaged Asia’s domesticated poultry and spread to

migratory birds that carried the virus from East Asia

through Kazakhstan, Russia, Turkey, southeastern

Europe and now East Africa.

 

Zakaria pointed out that the bird flu problem started

in China’s Guangdong Province. China’s development and

urbanization have reduced the country’s forests and

wetlands, he said, forcing migratory birds to gather

closer together and nearer to human habitation.

 

Although H5N1 does not — yet — transmit from human

to human, Dr. Henry I. Miller, a physician and fellow

at the Hoover Institution, warned in the Oct. 17 Wall

Street Journal’s “Reasons to Be Fearful,” that the

“flu virus mutates readily, and virologists expect

that sooner or later it will acquire the ability to

spread from person to person.” When the virus becomes

“highly transmissible” among humans, a worldwide

outbreak will become a reality. He said the mortality

rate of those infected with H5N1 is about 50 percent;

the “garden-variety annual flu” kills less than one

percent.

 

Of the 122 human cases of avian flu since December

2003, 62 have died.

 

The Nov. 2 Washington Post listed a Web site,

www.pandemicflu.gov, that suggests what every American

can do in the event of an outbreak. Public support for

strategies to limit contagion will be essential:

frequent hand-washing, travel restrictions during an

outbreak, self-imposed home quarantines of the ill,

and stockpiling of food and other essential items.

 

At present, Tamiflu is the only existing drug to

prevent the flu, and Relenza treats the flu. Tamiflu

is good as long as one takes the drug. But the H5N1

that infected a patient in Vietnam seems to be

resistant to Tamiflu.

 

While vaccine research focuses today on the H5N1 avian

flu virus, Zakaria called for a “massive biomedical

project” to tackle “all strains” of the flu, a tall

order, he confessed, but “it could be achieved.”

A. Gaffar Peang-Meth, Ph.D., is retired from the

University of Guam, where he taught political science

for 13 years. Write him at peangmeth@yahoo.com.

 

Originally published November 9, 2005